KRMD vs LRCX · rev $23.8M vs P/E 71, rev $23.23B
Repro Med Systems Inc (KRMD) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
Repro Med Systems Inc (KRMD) is a medical instruments & supplies company listed on US.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Latest reported KRMD revenue for 2026-06-30 was $23.8M. Net income was -$554.6K. KRMD currently screens at market cap $186.0M.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
KRMD currently screens at market cap $186.0M. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the KRMD and LRCX stock pages for the full models.
Not investment advice.